MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4254/wjh.v16.i12.1395

Медицинская библиотека · World journal of hepatology · 2024

Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus.

Li Hua-Dong, Liu Ya-Nan, Wu Shuang, Quan Xu-Feng, Wang Xiao-Yan, Xiang Tian-Dan, Li Shu-Meng, Xu Ling, Wang Tong, Wang Hua, Zheng Xin

СтатьяПеревод в очереди

Аннотация

BACKGROUND

The effect of nonalcoholic fatty liver disease (NAFLD) on the efficacy of nucleoside analogues (NAs) in antiviral therapy for patients with chronic hepatitis B (CHB) remains controversial.

AIM: To investigate the influence of NAFLD on virological response in CHB patients undergoing NAs treatment.

METHODS

Logistic regression analysis was conducted on a cohort of 465 CHB patients from two hospitals to determine whether NAFLD was a risk factor for adverse reactions to NAs. CHB patients were followed up for more than 28 months after initial antiviral treatment, and further validation was performed using different viral load populations.

RESULTS

NAFLD was identified as an independent risk factor for partial virological response following antiviral therapy with NAs (odds ratio = 1.777, P = 0.017). In our subsequent analysis focusing on CHB patients with high viral load, the NAFLD group exhibited significantly longer virus shedding time and lower proportion of the complete virological response compared with the non-NAFLD group (16.8 ± 6.1 vs 13.0 ± 6.8, P < 0.05). During the 24-month period of antiviral treatment with NAs, hepatitis B virus (HBV) DNA levels decreased slowly in the NAFLD group, and the negative conversion rate of HBV was notably lower than that observed in non-NAFLD group (P = 0.001). Similar results were obtained when analyzing patients with low baseline HBV viral load within the NAFLD group.

CONCLUSION

Coexistence of NAFLD may diminish virological response among CHB patients receiving antiviral treatment with NAs.

Для цитирования: Li Hua-Dong, Liu Ya-Nan, Wu Shuang, Quan Xu-Feng, Wang Xiao-Yan, Xiang Tian-Dan, Li Shu-Meng, Xu Ling, Wang Tong, Wang Hua, Zheng Xin. Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus.. World journal of hepatology. 2024. DOI: 10.4254/wjh.v16.i12.1395.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.